Complex regional pain syndrome type I: a comprehensive review

被引:72
|
作者
Bussa, M. [1 ]
Guttilla, D. [1 ]
Lucia, M. [2 ]
Mascaro, A. [3 ]
Rinaldi, S. [4 ]
机构
[1] St Antonio Abate Hosp, OU Anesthesia Intens Care & Pain Therapy, Casa Santa Erice, Trapani, Italy
[2] Azienda Osped Osped Riuniti, OU Anesthesia Intens Care & Pain Therapy, Palermo, Italy
[3] Univ Cattolica Sacro Cuore, Sch Med, Anaesthesiol Intens Care & Pain Therapy Dept, I-00168 Rome, Italy
[4] Univ Roma La Sapienza, Plast & Reconstruct Surg Dept, I-00185 Rome, Italy
关键词
REFLEX SYMPATHETIC DYSTROPHY; SPINAL-CORD STIMULATION; CONTROLLED-RELEASE OXYCODONE; RANDOMIZED CONTROLLED-TRIAL; IASP DIAGNOSTIC-CRITERIA; NEUROPATHIC PAIN; DOUBLE-BLIND; CORTICAL REORGANIZATION; NEUROGENIC INFLAMMATION; CENTRAL SENSITIZATION;
D O I
10.1111/aas.12489
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BackgroundComplex regional pain syndrome type I (CRPS I), formerly known as reflex sympathetic dystrophy (RSD), is a chronic painful disorder that usually develops after a minor injury to a limb. This topical review gives a synopsis of CRPS I and discusses the current concepts of our understanding of CRPS I in adults, the diagnosis, and treatment options based on the limited evidence found in medical literature. CRPS I is a multifactorial disorder. Possible pathophysiological mechanisms of CRPS I are classic and neurogenic inflammation, and maladaptive neuroplasticity. At the level of the central nervous system, it has been suggested that an increased input from peripheral nociceptors alters the central processing mechanisms. MethodsA literature search was conducted using, as electronic bibliographic database, Medline from 1980 until 2014. ResultsAn early diagnosis and multidisciplinary treatment are necessary to prevent permanent disability. ConclusionsThe pharmacological treatment of CRPS I is empirical and insufficiently effective. Further research is needed regarding the therapeutic modalities discussed in the guidelines. Physical therapy is widely recommended as a first-line treatment. The efficacy of local anesthetic sympathetic blockade as treatment for CRPS I is questionable.
引用
收藏
页码:685 / 697
页数:13
相关论文
共 50 条
  • [21] The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I
    Dirckx, Maaike
    Schreurs, MarcoW. J.
    de Mos, Marissa
    Stronks, Dirk L.
    Huygen, Frank J. P. M.
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [22] Rehabilitation approach of type I complex regional pain syndrome
    Novo Javier, Porro
    Perera Adonis, Estevez
    Dinorah Marisabel, Prada Hernandez
    Suarez Beatriz, Garrido
    Garcia Annia, Rodriguez
    REVISTA CUBANA DE REUMATOLOGIA, 2012, 14 (20): : 71 - 78
  • [23] Management of patients with complex regional pain syndrome type I
    Gatti, D.
    Rossini, M.
    Adami, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (08) : 2423 - 2431
  • [24] Management of patients with complex regional pain syndrome type I
    D. Gatti
    M. Rossini
    S. Adami
    Osteoporosis International, 2016, 27 : 2423 - 2431
  • [25] Focus on the bone in complex regional pain syndrome type I
    Laroche, Michel
    JOINT BONE SPINE, 2016, 83 (06) : 731 - 731
  • [26] Animal Models of Complex Regional Pain Syndrome Type I
    Liu, Yu
    Liang, Ying
    Gao, Min
    Li, Yingchun
    Zhao, Tingting
    Zhao, Yani
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 3711 - 3721
  • [27] Efficacy of pamidronate in complex regional pain syndrome type I
    Robinson, JN
    Sandom, J
    Chapman, PT
    PAIN MEDICINE, 2004, 5 (03) : 276 - 280
  • [29] Hypoxia in complex regional pain syndrome type I.
    Gorodkin, R
    Jesiorska, M
    Freemont, A
    Stratford, I
    Herrick, A
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S518 - S518
  • [30] Drug therapy in complex regional pain syndrome type I
    von Eisenhart-Rothe, R
    Rittmeister, M
    ORTHOPADE, 2004, 33 (07): : 796 - +